Druggist

JANUARY 4, 2021

Licensed use of flucloxacillin and amoxicillin. Licensed use of flucloxacillin and amoxicillin. The difference in the licensed use between flucloxacillin and amoxicillin is the main driving factor for significant variation in prescribing of both drugs. This post focuses on highlighting the main differences between drugs.

Bacteria 98

Bacteria Licensing Licensing Drugs 98

Pharmaceutical Technology

OCTOBER 28, 2022

The company says that these four serotypes represent roughly 10–15% of bacteria causing pneumococcal disease in adults. Pneumococcal vaccines are used to inoculate individuals against infections caused by the Streptococcus pneumoniae bacteria. This is in addition to its long-available pneumococcal polysaccharide vaccine PPSV23.

Vaccination 162

Vaccination Vaccine Marketing Bacteria 162

XTalks

MAY 4, 2022

In order to reach a critical mass of bacteria for testing, food samples must be incubated to allow bacteria to grow. Atencia initially developed the technology at the National Institute of Standards and Technology (NIST) and the University of Maryland before it was licensed to the company.

Bacteria 98

Bacteria Marketing Engineer Licensing 98

Scienmag

NOVEMBER 9, 2020

After each wear however, bacteria from even a healthy […]. Scientist invents novel device to conveniently sanitize contaminated masks at home or at work Credit: Patrick Grant, Ph.D.,

Contamination 74

Contamination Bacteria Scientist Licensing 74

pharmaphorum

JUNE 20, 2022

The deal gives Valneva a cash injection that it will be able to use to advance Lyme disease candidate VLA15 towards the market, but the revised licensing terms means that the French biotech will shoulder more of the financial cost of the development programme. Pfizer has acquired an 8.1%

Vaccination 97

Vaccination Vaccine Licensing Licensing 97

pharmaphorum

DECEMBER 15, 2020

Globally, 15-25% of women are colonised with GBS, and they run the risk of transmitting the bacteria to their child in utero, during birth and / or during their first months of life. These are capable of mobilising the immune system against GBS bacteria and preventing invasion of epithelial and endothelial cell barriers.

Bacteria 52

Bacteria Vaccination Vaccine Immune Response 52

Drug Discovery World

AUGUST 12, 2022

It works by targeting the outer surface protein A (OspA) of the bacteria that cause Lyme disease. If the Phase III trial is successful, Pfizer aims to submit a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) and Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) in 2025. .

Vaccination 52

Vaccination Vaccine Trials Bacteria 52

pharmaphorum

MAY 7, 2021

Nkarta also gets a license to CRISPR gene editing to an unlimited number of its own NK cell therapy products. The companies will bring together their cell therapy engineering and manufacturing expertise to develop a novel NK+T product candidate harnessing the synergies of the adaptive and innate immune systems.

Gene Editing 52

Gene Editing Gene Genetic Engineering DNA 52

pharmaphorum

AUGUST 7, 2020

LRRK2 regulates lysosomes, which play a vital role in cell function by breaking down excess or worn-out cell parts, and can also destroy invading viruses and bacteria. Mutations in the LRRK2 gene can cause Parkinson’s disease.

Bacteria 69

Bacteria Marketing Licensing Licensing 69

pharmaphorum

OCTOBER 27, 2022

The FDA has accepted for review Seres Therapeutics’ Biologics License Application (BLA) for SER-109, an investigational oral microbiome therapeutic for the prevention of recurrent Clostridium difficile infection (rCDI). If approved, SER-109 would be the first-ever FDA-approved oral microbiome therapeutic.

Bacteria 45

Bacteria FDA Approval Licensing Licensing 45

Druggist

NOVEMBER 13, 2020

Skin infection is usually caused by a group of bacteria called group A streptococcus (GAS) and Staphylococcus aureus. During the infection, bacteria release toxins, which cause quick, severe damage and death of the skin. NF may lead to a life-threatening situation. Aveeno Soothing Bath Treatment For Itchy, Irritated Skin, 8 Count.

Bacteria 98

Bacteria Medicine Production Drugs 98

XTalks

JULY 25, 2023

The bacteria usually enter the body through wounds, but infection can also occur through contaminated meat or inhalation of spores. Additionally, 533 participants received at least one dose of the comparator-licensed anthrax vaccine, BioThrax (Anthrax Vaccine Adsorbed). Anthrax is a rare, yet severe disease caused by the bacterium B.

FDA Approval 98

FDA Approval Vaccination Vaccine Antibody 98

Druggist

MARCH 17, 2021

Bacteria present inside the blocked pores grow and contribute to symptoms of acne. Antibacterial drugs such as lymecycline kill bacteria and stop acne development. . Although licensed for acne, minocycline is rarely prescribed in the UK. Oral antibiotics are effective in the treatment of moderate to severe acne (Strauss et al.,

Bacteria 59

Bacteria Dermatology Doctors Doctor 59

Druggist

JULY 29, 2020

The larger size of Eumovate cream and ointment (30g and 100g) tubes are licensed as prescription-only medicines and need to be prescribed by GP or another prescriber. OTC Eumovate is licensed in adults and children over 12 years of age. Children under 12 years of age can use Eumovate cream only under recommendation from a doctor.

Pharmacy 72

Pharmacy Doctors Doctor Licensing 72

pharmaphorum

OCTOBER 27, 2021

Lilly has also picked up an accelerated review for donanemab from the FDA, which is assessing the drug under a rolling license application that will see data submitted to the agency as it becomes available.

Trials 52

Trials Drugs Sales Bacteria 52

Druggist

SEPTEMBER 20, 2020

Daktarin Oral Gel is licensed for the treatment of oral baby thrush from 4 months of age. Parents of children younger than four months should speak to the GP, who may prescribe (outside of its license) the same gel or an alternative product – oral nystatin suspension.

Pharmacy 75

Pharmacy Doctors Doctor Licensing 75

Pfizer

FEBRUARY 16, 2023

The companies intend to work with regulatory authorities, and as previously announced, 1,2 aim for Pfizer to potentially submit a Biologics License Application (BLA) to the U.S. OspA is a surface protein expressed by the bacteria when present in a tick. Blocking OspA inhibits the bacterium’s ability to leave the tick and infect humans.

Clinical Trials 76

Clinical Trials Clinical Trials Vaccination Vaccine 76

Druggist

DECEMBER 2, 2020

Antiseptic creams are preparations which are applied to the skin to reduce the possibility of infections or to slow the growth of bacteria. Antiseptic creams have bacteriostatic properties (stops bacteria from multiplying) as opposed to antibiotic creams, which are bactericidal (kill the bacteria). . £21.99.

Bacteria 86

Bacteria Pharmacy Doctors Doctor 86

The Pharma Data

OCTOBER 26, 2020

The Company has generated multiple clinical stage mAbs targeting bacteria that cause life-threatening infections such as ventilator associated pneumonia (VAP) and hospital acquired pneumonia (HAP), in addition to preclinical stage antiviral mAbs. AR-711 (COVID-19). AR-201 (RSV infection).

Antibody 52

Antibody Genetic Engineering Development Clinical Trials 52

Pharmaceutical Technology

FEBRUARY 26, 2023

The idea behind these treatments relies on altering the gut microbiome by designing therapeutics that contain bacteria derived from donated stool samples. Unlike Rebyota and SER-109, Vedanta’s treatment is based on clonal bacteria strains and does not use donated stool samples. Vedanta is a subsidiary of Puretech Health.

Bacteria 278

Bacteria Trials Research Medicine 278

Drug Discovery World

MAY 6, 2024

The transfer of technologies from the lab to the market, is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates. This enabled the Basel start-up ecosystem to grow considerably and consistently, with a strong acceleration in the last five to 10 years.

Drugs 59

Drugs Life Science Gene Editing Gene 59

The Pharma Data

OCTOBER 19, 2020

There are more than 90 different types of pneumococcal bacteria which can affect adults differently than children. Pneumococcal serotypes not in the currently licensed conjugate vaccine, such as 22F and 33F, are among the most common serotypes causing invasive pneumococcal disease in parts of the world, including the U.S.,

Vaccination 52

Vaccination Vaccine Immune Response Containment 52

Druggist

OCTOBER 4, 2020

Lepicol has a rather unique formula of three different ingredients: Psyllium husk Live bacteria Insulin (a fibre from chicory root and not the Insulin produced by the pancreatic cells) As advertised the Insulin (chicory root) is not broken down by the body, but fermented by live bacteria to support the growth of natural bacterial flora in the gut.

Containment 98

Containment Pharmacy Bacteria Sales 98

Druggist

SEPTEMBER 1, 2020

Common drugs that can cause an acute episode of diarrhoea include: Antibiotics Antacids (especially magnesium-containing) Proton Pump Inhibitors (PPIs) such as omeprazole or esomeprazole Orlistat (weigh loss medication) Metformin ( anti-diabetic drug ) A virus, bacteria or parasites can cause acute episodes of diarrhoea.

Pharmacy 59

Pharmacy Containment Branding Sales 59

XTalks

JULY 6, 2021

CDIs usually develop after treatments with antibiotics as they can kill off healthy bacteria in the gut in the process of targeting the pathogenic bacteria. As part of the deal with Nestlé, Seres will receive license payments of $175 million up front with an additional $125 million upon FDA approval of the drug.

Marketing 105

Marketing Drugs Bacteria FDA Approval 105

Delveinsight

DECEMBER 18, 2020

Brain infection from parasites (malaria, neurocysticercosis), viruses (influenza, dengue, Zika), and bacteria. For instance, in England, Scotland and Wales you need to tell the Driver and Vehicle Licensing Agency (DVLA). Severe Head Injury. Lack/ loss of oxygen to the brain (especially during birth). Drug or alcohol abuse.

Doctors 52

Doctors Doctor Drugs Development 52

The Pharma Data

DECEMBER 2, 2020

aeruginosa bacteria, instead of killing the bacteria as an antibiotic would aim to do. Vivlion holds an exclusive license to Goethe University of Frankfurt’s proprietary 3Cs technology for the production of next generation 3Cs CRISPR/Cas gRNA libraries. Horizon Discovery Group – U.K.-based in Mainland China.

Drugs 52

Drugs Gene Editing Genome Genomics 52

Drug Discovery World

APRIL 25, 2024

It’s an essential step in determining whether a therapy is effective and can help reduce the cost and time it takes when bringing a drug to market by enabling researchers to submit investigational new drug (IND) or a biologics license application (BLA) to the Food and Drug Administration (FDA).

Development 59

Development Protein In-Vivo Life Science 59

pharmaphorum

MAY 31, 2022

Last year, Affinivax reported positive phase 2 results with ASP3772, which targets 24 of the common serotypes of Streptococcus pneumoniae – a bacteria which causes non-invasive illnesses like pneumonia, sinusitis and middle ear infections, as well as invasive diseases like meningitis.

Vaccination 52

Vaccination Vaccine Bacterium Sales 52

Druggist

AUGUST 27, 2020

Recently, Tyrozets were discontinued due to ”misuse” of antibiotic (one of the active ingredients) in the treatment of sore throats, which are mostly caused by viruses and not bacteria. Looking at the withdrawal of Tyrozets from the market, MHRA may question the licensed use of Dequadin lozenge in the management of sore throats.

Containment 98

Containment Pharmacy Production Sales 98

The Pharma Data

DECEMBER 23, 2020

based Avacta Group entered into a license agreement with Astrea Bioseparations that allows that company to use Avacta’s Affimer platform in affinity purification applications. Peijia received an exclusive license regarding certain proprietary TMVR products currently in development by HighLife.

Drugs 52

Drugs Licensing Licensing Vaccination 52

The Pharma Data

DECEMBER 15, 2020

These proinflammatory T cells promoted bacterial clearance after infection with Staphylococcus aureus and, by licensing encephalitogenic Th17 cells, played a key role in the development of autoimmune disease in the central nervous system,” the authors stated. Patient Recruitment.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

The Pharma Data

JUNE 18, 2021

We are thrilled with this approval as it furthers our mission to expand protection against disease-causing bacteria serotypes to help prevent potentially serious respiratory infections like pneumococcal pneumonia throughout the year.”. Global President of Pfizer Vaccines. “We About 20-Valent Pneumococcal Conjugate Vaccine Regulatory Review.

Vaccination 52

Vaccination Vaccine FDA Approval Containment 52

XTalks

AUGUST 2, 2023

Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. In 2022, the FDA proceeded to grant official licensing for Moderna’s Spikevax COVID-19 vaccine.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Delveinsight

SEPTEMBER 7, 2021

California-based pharma company Forte has been testing FB-401 , which comprises three therapeutic strains of a commensal gram-negative bacteria, as a possible therapy for atopic dermatitis. Versanis Bio, an Oakland, Calif-based company has licensed Novartis’s Bimagrumab drug rights and raised $70 million for mid-stage clinical testing.

Vaccination 70

Vaccination Vaccine Antibody Trials 70